Komori
Medical System Network (4350) · TargetWorsenedLatest Earnings presentation materials (2026-11-10): "Mitigated"

Ensuring financial soundness and improving the equity ratio

First written in FY2016. 14 of 28 entries say "Advanced", first in FY2019-Q2. Latest entry: 2026-11-10.

28entries
11years
4from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2016 – FY2017AdvancedFY2021-Q2 – FY20222016: 220162017: 120172018: 220182019: 320192020: 320202021: 320212022: 320222023: 320232024: 120242025: 220252026: 52026
Same theme, other companies
Optimal capital structure with a 40–50% equity ratio as a benchmarkA theme 55 companies write about · 4 as a headwind · 49 as a tailwind

The whole theme swung hardest in 2019: 3 of 29 companies on the "Worse" side.

0 other companies' latest entry also says "Mitigated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 55 companies compared. The sentences above are computed from all 55.
Full recordFilings, disclosures and news, newest first
  1. FY2026WorsenedAnnual report

    「Equity ratio (%) 21.6」

    The equity ratio declined from 23.0% in the previous fiscal year to 21.6%, widening the gap with the 30.0% target under the Sixth Medium-Term Management Plan.
  2. FY2026-H1AdvancedAnnual report

    「Equity ratio (%) 21.7 23.2 23.0」

    The equity ratio rose slightly from 23.0% at the end of March 2025 to 23.2% at the end of September 2025. A gap remains relative to the Sixth Medium-Term Management Plan target of 30.0%.
  3. FY2025AdvancedAnnual report

    「The interest-bearing debt dependence ratio of our group, defined as interest-bearing debt as a percentage of total assets, was 42.2% for the consolidated fiscal year. We intend to improve our financial position by increasing profitability and strengthening shareholders' equity.」

    The equity ratio rose from 22.3% at the end of March 2024 to 23.0%, while the interest-bearing debt dependence ratio was 42.2%. Although a gap remains relative to the Sixth Medium-Term Management Plan's equity ratio target of 30.0%, financial indicators improved from the previous fiscal year.
  4. FY2025-H1WorsenedAnnual report

    「Equity ratio (%) 22.9 21.7 22.3」

    The equity ratio fell from 22.3% at the end of the previous consolidated fiscal year to 21.7% at the end of September 2024. The gap relative to the Sixth Medium-Term Management Plan's final-year target of 30.0% widened.
  5. FY2024-Q2AdvancedAnnual report

    「Equity ratio (%) 21.2 22.9 21.8」

    The equity ratio rose from 21.8% at the end of March 2023 to 22.9% at the end of September 2023. It remains some distance from the Sixth Medium-Term Management Plan target of 30.0%.
  6. FY2024-Q1WorsenedAnnual report

    「Equity ratio (%) 20.2 21.2 21.8」

    The equity ratio fell from 21.8% at the end of March 2023 to 21.2% at the end of June 2023. The gap relative to the Sixth Medium-Term Management Plan's final-year target of 30.0% widened.
  7. FY2023-Q3WorsenedAnnual report

    「Equity ratio (%) 20.6 21.1」

    The equity ratio fell from 21.1% at the end of the previous consolidated fiscal year to 20.6% as of 31 December 2022. A gap remains relative to the Sixth Medium-Term Management Plan's final-year target of 30.0%.
  8. FY2023-Q2AdvancedAnnual report

    「Equity ratio (%) 20.0 21.2 21.1」

    The equity ratio rose slightly from 21.1% at the end of the previous consolidated fiscal year to 21.2%. It remains some distance from the Sixth Medium-Term Management Plan's final-year target of 30.0%.
  9. FY2023-Q1WorsenedAnnual report

    「Equity ratio (%) 18.6 20.2 21.1」

    The equity ratio fell from 21.1% at the end of the previous fiscal year to 20.2% at the end of June 2022, widening the gap relative to the Sixth Medium-Term Management Plan's final-year target of 30.0%.
  10. FY2022AdvancedAnnual report

    「The equity ratio was 21.1%.」

    The equity ratio rose from 17.3% in the previous fiscal year to 21.1%. It remains some distance from the Sixth Medium-Term Management Plan's final-year target of 30.0%.
  11. FY2022-Q2AdvancedAnnual report

    「Liabilities totaled ¥49,928 million, a decrease of ¥3,332 million from the end of the previous consolidated fiscal year. Non-current liabilities totaled ¥25,811 million, a decrease of ¥2,030 million. This was mainly due to a decrease in long-term borrowings. The equity ratio was 20.0%.」

    Liabilities, including long-term borrowings, decreased, and the equity ratio rose from 17.3% at the end of the previous fiscal year to 20.0%.
  12. FY2021AdvancedAnnual report

    「The equity ratio was 17.3%.」

    The equity ratio rose from 14.2% at the end of the previous consolidated fiscal year to 17.3%. It remains some distance from the Fifth Medium-Term Management Plan target of an equity ratio of 30% or higher.
  13. FY2021-Q3AdvancedAnnual report

    「Equity ratio (%) 16.0 16.7 14.2」

    The equity ratio was 16.7% at the end of the third quarter, up from 14.2% at the end of the previous consolidated fiscal year. It remains some distance from the target of 30% or higher for the fiscal year ending March 2022 under the Fifth Medium-Term Management Plan.
  14. FY2021-Q2AdvancedAnnual report

    「Equity ratio (%) 16.2 15.5 14.2」

    The equity ratio rose from 14.2% at the end of March 2020 to 15.5% at the end of September 2020. It remains some distance from the Fifth Medium-Term Management Plan target of an equity ratio of 30% or higher.
  15. FY2021-Q1WorsenedAnnual report

    「Equity ratio (%) 15.8 13.8 14.2」

    The equity ratio was 13.8% at the end of the first quarter, down from 14.2% at the end of March 2020. The gap relative to the plan target of an equity ratio of 30% or higher for the fiscal year ending March 2022 has widened.
  16. FY2020-Q3AdvancedAnnual report

    「Equity ratio (%) 16.4 16.0 15.6」

    The equity ratio rose from 15.6% at the end of March 2019 to 16.0% at the end of December 2019. It remains some distance from the target of 30% or higher for the fiscal year ending March 2022 under the Fifth Medium-Term Management Plan.
  17. FY2020-Q2AdvancedAnnual report

    「Equity ratio (%) 17.4 16.2 15.6」

    The equity ratio was 16.2% at the end of the second quarter, up from 15.6% at the end of March 2019 and 15.8% at the end of the first quarter. It remains some distance from the plan target of 30% or higher for the fiscal year ending March 2022.
  18. FY2020-Q1AdvancedAnnual report

    「Equity ratio (%) 17.2 15.8 15.6」

    The equity ratio rose slightly from 15.6% at the end of March 2019 to 15.8% at the end of June 2019. It remains some distance from the target of 30% or higher for the fiscal year ending March 2022 under the Fifth Medium-Term Management Plan.
  19. FY2019-Q3WorsenedAnnual report

    「Equity ratio (%) 17.5 16.4 16.9」

    The equity ratio was 16.4% at the end of the third quarter, below 16.9% at the end of the previous consolidated fiscal year and 17.5% in the same period of the previous year. The numerical gap relative to the Fifth Medium-Term Management Plan target of 30% or higher has widened.
  20. FY2019-Q2AdvancedAnnual report

    「Equity ratio (%) 17.4」

    The equity ratio rose from 16.9% for the fiscal year ended March 2018 to 17.4%. It remains some distance from the target of 30% or higher for the fiscal year ending March 2022 under the Fifth Medium-Term Management Plan.
  21. FY2018RaisedAnnual report

    「• Equity ratio           30% or higher」

    The Fifth Medium-Term Management Plan explicitly set, for the first time, a deadline-based quantitative target of an equity ratio of 30% or higher for the fiscal year ending March 2022. The equity ratio was 16.9% for the fiscal year ended March 2018.
  22. FY2017ReintroducedAnnual report

    「In addition to expanding the scale of the business, we will seek to ensure financial soundness by taking into account the balance between operating cash flow and investment, the equity ratio, and other factors.」

    Ensuring financial soundness, which had not been explicitly presented in disclosures since the first quarter, was stated again in the full-year management indicators and response policies.
  23. FY2017-Q1DroppedAnnual report
  24. FY2016First statedAnnual report

    「Maintaining Financial Soundness」

    The policy is to expand the pharmaceuticals and other network businesses, which have high profit margins, while maintaining a balance between operating cash flow and investment.
Moved together

"Risk of Reliance on Interest-Bearing Debt and Failure to Improve Financial Strength" moved the same way as this thread, in the same document, in 19 of its 28 moves.

191616141313★123456
  1. ★This thread
  2. 1Risk of Reliance on Interest-Bearing Debt and Failure to Improve Financial Strength19×
  3. 2Absorbing the Impact of Drug Price and Dispensing Fee Revisions and Returning to a Growth Trajectory16×
  4. 3Cost, Safety and Quality Improvements and Area Expansion in the Food Service Business16×
  5. 4Expansion of the Pharmaceutical Network14×
  6. 5Promoting Generic Drug Use and Initiatives for Home Healthcare13×
  7. 6Expansion of the dispensing pharmacy store network13×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Medical System Network's next results are scheduled for 2026-11-10. Read the earnings preview It last moved in the Earnings presentation materials of 2026-11-10: "Mitigated".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.